Publication details
KDO_DC1311 Zpráva o průběhu klinického hodnocení Annual Report za období 10. září 2023 ‒ 9. září 2024
| Title in English | KDO_DC1311 Report on the progress of the clinical trial Annual Report for the period September 10, 2023 - September 9, 2024 |
|---|---|
| Authors | |
| Year of publication | 2024 |
| Type | Research report |
| MU Faculty or unit | |
| web | KDO_DC1311 |
| Description | The annual report gives the overview of the conduct of the clinical trial „Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors“. The primary aim of the clinical trial is to study the safety of inovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor. |